» Articles » PMID: 25897336

Graphene As Cancer Theranostic Tool: Progress and Future Challenges

Overview
Journal Theranostics
Date 2015 Apr 22
PMID 25897336
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Nowadays cancer remains one of the main causes of death in the world. Current diagnostic techniques need to be improved to provide earlier diagnosis and treatment. Traditional therapy approaches to cancer are limited by lack of specificity and systemic toxicity. In this scenario nanomaterials could be good allies to give more specific cancer treatment effectively reducing undesired side effects and giving at the same time accurate diagnosis and successful therapy. In this context, thanks to its unique physical and chemical properties, graphene, graphene oxide (GO) and reduced graphene (rGO) have recently attracted tremendous interest in biomedicine including cancer therapy. Herein we analyzed all studies presented in literature related to cancer fight using graphene and graphene-based conjugates. In this context, we aimed at the full picture of the state of the art providing new inputs for future strategies in the cancer theranostic by using of graphene. We found an impressive increasing interest in the material for cancer therapy and/or diagnosis. The majority of the works (73%) have been carried out on drug and gene delivery applications, following by photothermal therapy (32%), imaging (31%) and photodynamic therapy (10%). A 27% of the studies focused on theranostic applications. Part of the works here discussed contribute to the growth of the theranostic field covering the use of imaging (i.e. ultrasonography, positron electron tomography, and fluorescent imaging) combined to one or more therapeutic modalities. We found that the use of graphene in cancer theranostics is still in an early but rapidly growing stage of investigation. Any technology based on nanomaterials can significantly enhance their possibility to became the real revolution in medicine if combines diagnosis and therapy at the same time. We performed a comprehensive summary of the latest progress of graphene cancer fight and highlighted the future challenges and the innovative possible theranostic applications.

Citing Articles

Application of loaded graphene oxide biomaterials in the repair and treatment of bone defects.

Xing J, Liu S Bone Joint Res. 2024; 13(12):725-740.

PMID: 39631429 PMC: 11617066. DOI: 10.1302/2046-3758.1312.BJR-2024-0048.R1.


Preparation and characterization of calcium-doped graphene oxide-chitosan Nanocarrier to enhance the gene delivery in MCF-7 cell line.

Bidgoli A, Farmany A, Taheri M, Soleimani M, Nouri F Sci Rep. 2024; 14(1):27434.

PMID: 39521829 PMC: 11550409. DOI: 10.1038/s41598-024-78958-3.


Carbon nanomaterials as carriers for the anti-cancer drug doxorubicin: a review on theoretical and experimental studies.

Gayathri K, Vidya R Nanoscale Adv. 2024; 6(16):3992-4014.

PMID: 39114152 PMC: 11302188. DOI: 10.1039/d4na00278d.


Shedding light on the use of graphene oxide-thiosemicarbazone hybrids towards the rapid immobilisation of methylene blue and functional coumarins.

Bradley D, Sarpaki S, Mirabello V, Giuffrida S, Kociok-Kohn G, Calatayud D Nanoscale Adv. 2024; 6(9):2287-2305.

PMID: 38694476 PMC: 11059481. DOI: 10.1039/d3na01042b.


Evaluation of the Antibacterial, Anti-Cervical Cancer Capacity, and Biocompatibility of Different Graphene Oxides.

Castro J, Payan-Valero A, Valencia-Llano C, Insuasty D, Rodriguez Macias J, Ordonez A Molecules. 2024; 29(2).

PMID: 38257194 PMC: 10821421. DOI: 10.3390/molecules29020281.


References
1.
Hirsch L, Stafford R, Bankson J, Sershen S, Rivera B, Price R . Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci U S A. 2003; 100(23):13549-54. PMC: 263851. DOI: 10.1073/pnas.2232479100. View

2.
Geim A, Novoselov K . The rise of graphene. Nat Mater. 2007; 6(3):183-91. DOI: 10.1038/nmat1849. View

3.
Zhang H, Yee D, Wang C . Quantum dots for cancer diagnosis and therapy: biological and clinical perspectives. Nanomedicine (Lond). 2008; 3(1):83-91. DOI: 10.2217/17435889.3.1.83. View

4.
Khdair A, Gerard B, Handa H, Mao G, Shekhar M, Panyam J . Surfactant-polymer nanoparticles enhance the effectiveness of anticancer photodynamic therapy. Mol Pharm. 2008; 5(5):795-807. DOI: 10.1021/mp800026t. View

5.
Delogu L, Magrini A, Bergamaschi A, Rosato N, Dawson M, Bottini N . Conjugation of antisense oligonucleotides to PEGylated carbon nanotubes enables efficient knockdown of PTPN22 in T lymphocytes. Bioconjug Chem. 2009; 20(3):427-31. DOI: 10.1021/bc800540j. View